195 related articles for article (PubMed ID: 27694491)
21. Alteration of naïve and memory B-cell subset in chronic graft-versus-host disease patients after treatment with mesenchymal stromal cells.
Peng Y; Chen X; Liu Q; Xu D; Zheng H; Liu L; Liu Q; Liu M; Fan Z; Sun J; Li X; Zou R; Xiang AP
Stem Cells Transl Med; 2014 Sep; 3(9):1023-31. PubMed ID: 25015640
[TBL] [Abstract][Full Text] [Related]
22. Decreased interleukin 10 and increased interferon-gamma production in patients with chronic graft-versus-host disease after allogeneic bone marrow transplantation.
Körholz D; Kunst D; Hempel L; Söhngen D; Heyll A; Bönig H; Göbel U; Zintl F; Burdach S
Bone Marrow Transplant; 1997 Apr; 19(7):691-5. PubMed ID: 9156246
[TBL] [Abstract][Full Text] [Related]
23. Plasmacytoid dendritic cell heterogeneity is defined by CXCL10 expression following TLR7 stimulation.
Marsman C; Lafouresse F; Liao Y; Baldwin TM; Mielke LA; Hu Y; Mack M; Hertzog PJ; de Graaf CA; Shi W; Groom JR
Immunol Cell Biol; 2018 Nov; 96(10):1083-1094. PubMed ID: 29870118
[TBL] [Abstract][Full Text] [Related]
24. Heightened TLR7 signaling primes BCR-activated B cells in chronic graft-versus-host disease for effector functions.
Bracken SJ; Suthers AN; DiCioccio RA; Su H; Anand S; Poe JC; Jia W; Visentin J; Basher F; Jordan CZ; McManigle WC; Li Z; Hakim FT; Pavletic SZ; Bhuiya NS; Ho VT; Horwitz ME; Chao NJ; Sarantopoulos S
Blood Adv; 2024 Feb; 8(3):667-680. PubMed ID: 38113462
[TBL] [Abstract][Full Text] [Related]
25. Significant differences in B-cell subpopulations characterize patients with chronic graft-versus-host disease-associated dysgammaglobulinemia.
Kuzmina Z; Greinix HT; Weigl R; Körmöczi U; Rottal A; Frantal S; Eder S; Pickl WF
Blood; 2011 Feb; 117(7):2265-74. PubMed ID: 21063025
[TBL] [Abstract][Full Text] [Related]
26. Phenotypical and functional characterization of bone marrow mesenchymal stem cells in patients with chronic graft-versus-host disease.
Wang B; Hu Y; Liu L; Hu K; Tie R; He Y; Fu S; Zhu N; Luo Y; Yu X; Huang H
Biol Blood Marrow Transplant; 2015 Jun; 21(6):1020-8. PubMed ID: 25708216
[TBL] [Abstract][Full Text] [Related]
27. Enhanced expression of interferon-regulated genes in the liver of patients with chronic hepatitis C virus infection: detection by suppression-subtractive hybridization.
Patzwahl R; Meier V; Ramadori G; Mihm S
J Virol; 2001 Feb; 75(3):1332-8. PubMed ID: 11152506
[TBL] [Abstract][Full Text] [Related]
28. Increased expression of interferon-λ in minor salivary glands of patients with primary Sjögren's syndrome and its synergic effect with interferon-α on salivary gland epithelial cells.
Ha YJ; Choi YS; Kang EH; Chung JH; Cha S; Song YW; Lee YJ
Clin Exp Rheumatol; 2018; 36 Suppl 112(3):31-40. PubMed ID: 28421993
[TBL] [Abstract][Full Text] [Related]
29. Low-density neutrophils in chronic graft versus host disease (cGVHD) are primarily immature CD10
Matthews NC; Burton CS; Alfred A
Clin Exp Immunol; 2021 Aug; 205(2):257-273. PubMed ID: 33932293
[TBL] [Abstract][Full Text] [Related]
30. Skin ulcers related to chronic graft-versus-host disease: clinical findings and associated morbidity.
Jachiet M; de Masson A; Peffault de Latour R; Rybojad M; Robin M; Bourhis JH; Xhaard A; Dhedin N; Sicre de Fontbrune F; Suarez F; Barete S; Parquet N; Nguyen S; Ades L; Rubio MT; Wittnebel S; Bagot M; Socié G; Bouaziz JD
Br J Dermatol; 2014 Jul; 171(1):63-8. PubMed ID: 24404963
[TBL] [Abstract][Full Text] [Related]
31. Circulating endothelial progenitor cells decreased in patients with sclerodermatous chronic graft-versus-host disease.
Shimura K; Ashihara E; Shimazaki C; Matsunaga S; Taniguchi K; Uchiyama H; Matsumoto Y; Kimura S; Matsubara H; Taniwaki M; Maekawa T
Biol Blood Marrow Transplant; 2008 Apr; 14(4):426-37. PubMed ID: 18342785
[TBL] [Abstract][Full Text] [Related]
32. Epstein-Barr virus lytic infection promotes activation of Toll-like receptor 8 innate immune response in systemic sclerosis monocytes.
Farina A; Peruzzi G; Lacconi V; Lenna S; Quarta S; Rosato E; Vestri AR; York M; Dreyfus DH; Faggioni A; Morrone S; Trojanowska M; Farina GA
Arthritis Res Ther; 2017 Feb; 19(1):39. PubMed ID: 28245863
[TBL] [Abstract][Full Text] [Related]
33. [Chronic graft-versus-host-disease involving the oral mucosa: clinical presentation and treatment].
Elad S; Levitt M; M Y S
Refuat Hapeh Vehashinayim (1993); 2008 Nov; 25(4):19-27, 72. PubMed ID: 19263864
[TBL] [Abstract][Full Text] [Related]
34. Circulating monocyte subsets in human chronic graft-versus-host disease.
Konuma T; Kohara C; Watanabe E; Mizukami M; Nagai E; Oiwa-Monna M; Tanoue S; Isobe M; Jimbo K; Kato S; Takahashi S; Tojo A
Bone Marrow Transplant; 2018 Dec; 53(12):1532-1540. PubMed ID: 29728699
[TBL] [Abstract][Full Text] [Related]
35. Donor Th17 cells and IL-21 may contribute to the development of chronic graft-versus-host disease after allogeneic transplantation.
Zhao XY; Lv M; Xu LL; Qian X; Huang XJ
Eur J Immunol; 2013 Mar; 43(3):838-50. PubMed ID: 23280509
[TBL] [Abstract][Full Text] [Related]
36. Aberrant germinal center formation, follicular T-helper cells, and germinal center B-cells were involved in chronic graft-versus-host disease.
Shao L; Lie AK; Zhang Y; Wong CH; Kwong YL
Ann Hematol; 2015 Sep; 94(9):1493-504. PubMed ID: 25963280
[TBL] [Abstract][Full Text] [Related]
37. Risk Factors and Outcome of Chronic Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation-Results from a Single-Center Observational Study.
Grube M; Holler E; Weber D; Holler B; Herr W; Wolff D
Biol Blood Marrow Transplant; 2016 Oct; 22(10):1781-1791. PubMed ID: 27343720
[TBL] [Abstract][Full Text] [Related]
38. Polymorphisms in CXCR3 ligands predict early CXCL9 recovery and severe chronic GVHD.
Dai H; Rachakonda SP; Penack O; Blau IW; Blau O; Radujkovic A; Müller-Tidow C; Dreger P; Kumar R; Luft T
Blood Cancer J; 2021 Feb; 11(2):42. PubMed ID: 33640906
[TBL] [Abstract][Full Text] [Related]
39. The expression pattern of interferon-inducible proteins reflects the characteristic histological distribution of infiltrating immune cells in different cutaneous lupus erythematosus subsets.
Wenzel J; Zahn S; Mikus S; Wiechert A; Bieber T; Tüting T
Br J Dermatol; 2007 Oct; 157(4):752-7. PubMed ID: 17714558
[TBL] [Abstract][Full Text] [Related]
40. Suppressor function of liver mononuclear cells isolated during murine chronic graft-vs-host disease. II. Role of prostaglandins and interferon-gamma.
Howell CD; Yoder TY; Vierling JM
Cell Immunol; 1992 Mar; 140(1):54-66. PubMed ID: 1531454
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
